Supplementary Fig. S2 from Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer
Authors:
- Elena ShagisultanovaESElena Shagisultanova
- William GradisharWGWilliam Gradishar
- Ursa Brown-GlabermanUBUrsa Brown-Glaberman
- Pavani ChalasaniPCPavani Chalasani
- Andrew J. BrennerABAndrew J. Brenner
- Alison StopeckASAlison Stopeck
- Hannah ParrisHPHannah Parris
- Dexiang GaoDGDexiang Gao
- Tessa McSpaddenTMTessa McSpadden
- Jose MayordomoJMJose Mayordomo
- Jennifer R. DiamondJDJennifer R. Diamond
- Peter KabosPKPeter Kabos
Open Access
- 14 July 2023
- other
- Published by American Association for Cancer Research (AACR)